Position in INCR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,100
+$950 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 16 holders
Holding Since
Jun 2024
8 quarters on record
Common Shares in INCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $10,260 across 8 Drug Manufacturers - Specialty & Generic names. INCR ranks #5 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38 | $2,730 | |
| 2 | VTRS |
Viatris Inc
|
96 | $1,524 | |
| 3 | HLN |
Haleon plc
|
146 | $1,362 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
74 | $1,186 | |
| 5 | INCR |
Intercure Ltd.
This page
|
200 | $1,100 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
59 | $854 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
48 | $830 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
4 | $674 |
All Filings in INCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,100 | 1,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $150 | 1,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $182 | 1,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $328 | 1,000 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $294 | 1,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $280 | 1,000 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $402 | 1,000 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $402 | 1,000 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||